Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 45,100
+4,350 (10.67%)
Sep 19, 2025, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 498.98 billion as of September 19, 2025.
Market Cap
498.98B
Enterprise Value
454.01B
Revenue
29.43B
Ranking
n/a
PE Ratio
101.51
Stock Price
45,100.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 498.98B, an increase of 166.96%. That is a compound annual growth rate of 269.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 498.98B | 182.65% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.10T |
| ALTEOGEN | 25.28T |
| Yuhan | 8,693.59B |
| SK Biopharmaceuticals | 8,410.84B |
| Peptron | 6,744.58B |
| PharmaResearch | 6,431.19B |
| ABL Bio | 5,452.05B |